Blood eosinophil count as a prognostic biomarker in COPD

Area of Science:

• Pulmonology
• Biomarkers
• Chronic Obstructive Pulmonary Disease (COPD)

Background:

• Blood eosinophil count predicts inhaled corticosteroid response in COPD exacerbation prevention.
• Low blood eosinophil counts are linked to pneumonia risk in COPD patients on inhaled corticosteroids.
• The prognostic significance of blood eosinophil count in COPD requires further investigation.

Purpose of the Study:

• To investigate factors associated with blood eosinophil count in COPD.
• To determine the relationship between blood eosinophil count and mortality in COPD patients.

Main Methods:

• Merged cohorts from the Korean Obstructive Lung Disease (KOLD) and COPD in Dusty Area (CDA) studies (n=629).
• Categorized patients into high (≥5%), middle (2%-5%), and low (<2%) blood eosinophil count groups.
• Analyzed associations with clinical parameters and survival outcomes.

Main Results:

• Higher blood eosinophil counts correlated with longer six-minute walk distance, higher BMI, lower emphysema index, and higher IC/TLC ratio.
• Survival period significantly increased with higher blood eosinophil counts (low: 7.42 years, middle: 8.47 years, high: 9.52 years).
• Emphysema index was independently and negatively correlated with blood eosinophil count.

Conclusions:

• In COPD, lower blood eosinophil counts are independently associated with increased emphysema severity.
• Increased blood eosinophil counts are associated with longer survival periods in COPD patients.
• Blood eosinophil count serves as a potential prognostic biomarker in COPD management.